SUMMARY
INTRODUCTION
It has been estimated that gastroesophageal reflux disease (GERD) and functional dyspepsia (FD) represent the most common gastrointestinal diseases in the general population, with a rising prevalence worldwide [1, 2] . While heartburn is a cardinal symptom of GERD, there is consensus that abdominal discomfort or pain centered in the upper abdomen, as well as the absence of any organic esophageal lesions, is the primary symptom of FD. Abdominal pain or discomfort is often associated with bloating, nausea, heartburn, vomiting, etc. [3] . Although not life-threatening, patients with GERD or FD perceive the effects of their condition to a similar degree to patients with other serious chronic diseases [4, 5] .
Recently published studies have addressed the significant impairment of health-related quality of life (HRQoL) in patients suffering from GERD in the areas of eating and drinking, physical activity, psychological wellbeing, as well as reduced vitality and poor sleep [6] [7] [8] [9] [10] . Furthermore, studies have shown that the direct costs of GERD range between PPP$172 (purchasing power parity in US dollars) and PPP$176 per person per year, thus causing a substantial economic burden [11, 12] . On the other hand, FD has been shown to significantly reduce HRQoL in the domains of general health, vitality, and the emotional and mental health of the patients compared to the general population [13, 14] . A study analyzing patientreported costs and claims in the USA found that FD patients incurred additional expenses of more than US$2,000/year [15] .
Although previously published studies have addressed the significant impairment in HRQoL domains in patients suffering from GERD and FD separately, to the best of our knowledge none of them have compared the impact of GERD and FD on HRQoL.
The aim of this study was to distinguish which of these two diseases has a greater impact on HRQoL of affected patients.
METHODS
The current sample was extrapolated from a large crosssectional population-based study conducted in primary healthcare facilities in urban and rural areas of Serbia, regarding HRQoL of patients suffering from chronic non-transmittable diseases. The inclusion criteria were as follows: patients of both genders, aged 18-90 years, willing and able to participate in this study and complete the questionnaire.
GERD was diagnosed by primary care physicians and general internists according to the Montreal definition of GERD for population-based studies, which included patients with mild symptoms of heartburn and/or regurgitation occurring at least two days per week, or moderate/ severe symptoms of heartburn and/or regurgitation occurring at least one day per week [16] . FD was also diagnosed by primary care physicians and general internists based on the Rome III criteria for FD, and encompassed patients with at least one of the following symptoms: postprandial fullness, early satiety, epigastric burning, and epigastric pain; occurring for the last three months with the onset of symptoms at least six months prior to participating in the study [17] . The FD group included both patients with postprandial distress syndrome and those with epigastric pain syndrome. Classification of GERD and FD was performed according to the International Classification of Diseases, Tenth Revision (ICD-10). Exclusion criteria included other significant upper gastrointestinal disorders and complications of GERD, as well as other chronic nontransmittable diseases, which are known to greatly impair HRQoL (diabetes mellitus, angina pectoris, depression, chronic obstructive pulmonary disease, etc.) [18] . Inclusion and exclusion criteria ensured that only patients with GERD and FD were eligible for study participation.
The current study was approved by the local ethics committee. Written informed consent was obtained from all participants prior to study participation.
In the current study, the Serbian version of the generic self-administered Center for Disease Control and Prevention questionnaire (CDC-HRQOL-4) was used. The questionnaire is divided into three sets of questions regarding general well-being, usual activities limitations including work and leisure activities, and disease symptoms [19] . The participants of the study completed the questionnaire in the office of their PCPs. Previously published surveys had demonstrated that results from the CDC-HRQOL-4 questionnaire had good test/retest reliability and strong internal validity [19, 20] . In this respect, the questionnaire has an advantage over other HRQoL instruments with more difficult methodology and limited practical value [21] .
Statistical analysis
We used the propensity score method to match GERD and FD samples on variables such as age, gender, education, and adherence to therapy. The PSMATCH 2 Stata module was used for propensity scoring with one-to-one nearest neighbor matching on the following covariates: age, gender, education, and therapy administration [22] . The PS-MATCH 2 Stata technique was first published by Rosenbaum and Rubin [23] and represents a matched sampling method used to remove bias due to potential confounding factors. This matching technique is used mainly for analyzing causal effects in intervention studies; however, it is also used in typical observational studies, including those with a cross-sectional design.
The descriptive statistics, including the mean and standard deviation of numerical data, as well as the numerical values and percentages of categorical variables, were used to characterize the study sample. The Pearson χ 2 test was used to compare categorical variables between the GERD and FD populations, and the independent samples t-test and the Mann-Whitney U-test were used for the numerical variables. The level of significance was set at α = 0.05. The statistical analysis was performed using IBM SPSS Statistics, Version 20.0 (IBM Corp., Armonk, NY, USA).
RESULTS
The response for this survey was over 90%. The 2,472 participants suitable for analysis were divided into two groups based on the inclusion and exclusion criteria (1,236 diagnosed with GERD and 1,236 diagnosed with FD). All included participants were Caucasian. The sociodemographic characteristics of the participants are summarized in Table 1 . The study included 593 (48%) males, 643 (52%) females in the GERD group, 599 (48.5%) males, and 637 (51.5%) females in the FD group. The mean age in the GERD group was 50.8 years in the GERD group and 50.5 years in the FD group. There was no statistically significant difference regarding gender, age, level of education and therapy administration between the two groups. The OTC -over the counter; PCP -primary care physician education level of the participants was classified based on the International Standard Classification of Education into lower education level, which included participants with no education or primary education only; and higher education level, which included participants with secondary education, tertiary, and post-tertiary education. Self-rated health and number of unhealthy days are shown in Table 2 . Regarding current health status, 547 (44.7%) patients in the GERD group self-rated their health as fair or poor, compared to 510 (41.8%) patients in the FD group (p > 0.05). The mean number of mentally unhealthy days was 5.4 ± 7.4 days in the GERD group, vs. 6.3 ± 7.5 days in the FD group (p < 0.01). The mean number of activity limitation days was 4.4 ± 6.9 in the GERD group, compared to 5.3 ± 7.3 days in the FD group (p = 0.001).
There was no statistically significant difference between the two groups regarding the participants' self-rated health in the previous 30 days. In other criteria, however, there was a statistically significant difference observed between the two groups, all in favor of FD. The differences were specifically in the criteria regarding unhealthy days in the previous 30 days, physically unhealthy days in the previous 30 days, mentally unhealthy days in the previous 30 days, and activity limitation days in the previous 30 days.
In the GERD group, the mean number of days with poor sleep during the previous 30 days was 7.2 ± 7.6 compared to 8.4 ± 7.7 in the FD group (p < 0.001). Regarding physical pain, 114 (9.2%) patients had ≥ 14 pain limitation days, compared to 128 (10.4%) patients in the FD group.
On further analyzing the occurrence of symptoms in the previous 30 days, a statistically significant difference was observed regarding days with poor sleep, once again in favor of FD, as showed in Table 3 .
DISCU SSION
GERD and FD represent the most prevalent conditions in patients seeking a medical consultation for abdominal symptoms [24] . Traditionally, medical practitioners are focused on objective clinical findings and their treatment, while patients are mostly concerned with their symptoms. This difference is particularly important in cases of nonerosive reflux disease and FD, the distinguishing features of which are the absence of objective endoscopic findings. Thus, measuring HRQoL provides additional information beyond what could be obtained by standard clinical examination.
Indeed, studies have demonstrated that both GERD and FD carry a significant burden regarding impaired HRQoL in the domains of general health, mental and emotional well-being, as well as lower work productivity [25] . Unfortunately, none of these studies have compared the diseases regarding their effect on HRQoL, nor had they determined which disease patients on average deemed more troublesome.
To the best of our knowledge, this is the first study of this type worldwide. The validation of this study was achieved using adequate study methodology and reliable self-administered generic CDC-HRQOL-4 questionnaire. The questions, despite their brevity, captured the key concepts of health as defined by the World Health Organization back in 1948, "A state of complete physical, mental, and social well-being -not merely the absence of disease or infirmity" [26] . Today, there are many validated disease-specific instruments for GERD and FD. However, disease-specific instruments do not allow for comparisons with illnesses other than GERD and FD, nor with healthy individuals in the general population. Therefore, generic HRQoL measures are valuable in supplementing diseasespecific instruments and enabling a comparison between two different diseases.
Over 90% of participants who were asked to participate in this study completed the questionnaire. This is a representative sample of those affected by GERD and FD in the general population in Serbia. The previous studies reported the prevalence of overlap of GERD with FD around 7.5-8.4%, especially in the cases of non-erosive reflux disease [27] . Unrecognized syndrome overlap was thought to be an important factor in partial or complete proton pump inhibitor failure in GERD therapy. While the Rome II classification of functional gastrointestinal disorders classified syndromes by their prominent symptoms, it failed to identify sub-groups with a homogenous underlying pathophysiological mechanism [28] . After further pathophysiological studies, the Rome III criteria were developed to identify and distinguish between different syndromes within the functional gastrointestinal disorders group, especially FD [29] . To minimize the chance of syndrome overlapping, both GERD and FD were classified according to the current Montreal and Rome III protocols. Furthermore, statistical analysis showed no statistically significant difference between either of the groups regarding the use of self-administered over-the-counter medication and medication prescribed by primary care physicians, hence excluding the proton pump inhibitor failures as potentially unrecognized FD patients. In our study, there was no statistically significant difference between the two groups regarding sociodemographic characteristics. All the domains comprising the CDC-HRQOL-4 questionnaire were significantly impaired in both groups, with unhealthy days, physically unhealthy days, mentally unhealthy days, and activity limitation days as the areas of most marked disturbance. These results are consistent with previously published results [6, 13] . The "unhealthy days" variable has continuous, cardinal, and bounded (range = 0 to 30 days) mathematical properties and represents the briefest validated set of generic HRQoL measures, with minimal overlap with the "physically" and "mentally unhealthy days" variables in comparison with other instruments, hence the reliably describing HRQoL oscillations over a period of time. Regarding self-rated health, similar results were obtained from both groups [30] .
The CDC-HRQOL-4 questionnaire further revealed that FD led to greater disturbances of every-day functioning in regard to the criteria of physically healthy, mentally healthy, and activity limitation days [6, 13] . Patients with FD experienced more days with poor sleep compared to the GERD group. Sleep disorders are quite common medical problems, and have been associated with several diseases, including GERD and FD [10] .
CONCLUSION
The results of the study have shown significant impairment of HRQoL in both groups, but, surprisingly, patients with FD experienced more limitations to their every-day functioning in the areas of HRQoL compared to patients with GERD. Thus, while often underestimated and considered a minor public health problem compared to other chronic diseases, FD confers a significant burden to patients' HRQoL. We believe that the results of this study offer insight into the complex relationship between GERD, FD, and HRQoL impairment. A better understanding of these mechanisms may allow for better disease management in the future.
This study has several limitations. Firstly, the results reflected the status of the predominantly Caucasian population of a single country (Serbia). Another possible limitation is that the generic HRQoL instruments used to measure health domains tend to be more physical or mobility-based. Although the CDC-HRQoL-4 questionnaire allowed for the comparison of two different diseases regarding their effect on HRQoL, unfortunately we were unable to determine which symptoms patients with GERD and FD deemed most troublesome. We hope that this will be investigated in further studies.
